Cargando…
Intravenous immunoglobulin is safe and effective in controlling pre-existing paraneoplastic neuromuscular diseases in cancer patients treated with immune checkpoint inhibitors: two case reports and literature review
Immune checkpoint inhibitors cause rare but potentially fatal neuromuscular complications, leading to a concern to use these agents in cancer patients with pre-existing autoimmune or inflammatory neuromuscular diseases. We report two such patients with paraneoplastic dermatomyositis and “seronegativ...
Autores principales: | Xiong, Ge, Young, Richard Benjamin, Chow, Helen, Maverakis, Emanual, Maselli, Ricardo A., Richman, David Paul, Li, Tianhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350685/ https://www.ncbi.nlm.nih.gov/pubmed/37465116 http://dx.doi.org/10.3389/fonc.2023.1199195 |
Ejemplares similares
-
Intravenous Immunoglobulin for Management of Non-paraneoplastic Autoimmune Retinopathy
por: Fekri, Sahba, et al.
Publicado: (2020) -
Early intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with onconeural antibodies
por: Berzero, Giulia, et al.
Publicado: (2018) -
Potential effect of intravenous immunoglobulin against paraneoplastic cerebellar degeneration in progressive ovarian cancer
por: Shibata, Takashi, et al.
Publicado: (2020) -
Combined Immune Checkpoint Blockade and Stereotactic Ablative Radiotherapy Can Stimulate Response to Immunotherapy in Metastatic Melanoma: A Case Report
por: Moran, Angel, et al.
Publicado: (2019) -
Antiganglioside antibodies and paraneoplastic neuromuscular junction disorder?
por: Jazebi, Noushin, et al.
Publicado: (2020)